CHICAGO / Feb 19, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced a collaboration with OSF HealthCare, an integrated health system caring for patients throughout Illinois and Michigan, and Pointcore, Inc., a healthcare management and non-clinical shared services company, to help increase clinical and operational efficiencies, standardize care delivery models and improve patient outcomes across OSF HealthCare. This alliance will leverage GE HealthCare’s expertise and innovative technology and Pointcore’s decades of experience managing nonclinical matters for hospitals and clinics. It will also support the Mission of OSF HealthCare to deliver exceptional care to patients in the communities they serve.
“In the rapidly changing world of healthcare, this strategic collaboration between OSF HealthCare, Pointcore and GE HealthCare means that we can ensure our Mission Partners (employees) have the right technology at the right place at the right time, fundamentally changing the way we deliver care to over one million patients each year,” said Jim Mormann, Chief Executive Officer of OSF HealthCare Integrated Solutions and Pointcore, Inc. “It is in direct alignment with our Mission to serve with the greatest care and love to all the communities we have been called to serve and aims to allow our patients to have access to the best care possible.”
The agreements stand on two key pillars and will deepen OSF HealthCare, Pointcore and GE HealthCare’s combined focus on:
OSF HealthCare, Pointcore and GE HealthCare expect to explore ways to scale their approach to drive greater access to personalized care for more patients. The alliance will concentrate on enhancing precision care in oncology by identifying clinical and technological opportunities that can help accelerate integrated cancer care at OSF HealthCare. The parties will work together to build pathways that deliver precise, personalized care for patients through customized solutions in radiation oncology and Theranostics for diseases like prostate cancer.
“The most critical goal of this collaboration is increasing access to quality care for all patients no matter where they are,” said Catherine Estrampes, President and CEO, U.S. and Canada at GE HealthCare. “OSF HealthCare, Pointcore and GE HealthCare are doing this together through integrated technology, digital solutions, advanced analytics and dedicated clinical and operational specialists. The work of our combined teams will help enable OSF HealthCare to standardize care across their system and empower their Mission Partners to focus on their patients and communities.”
The agreement is the result of extensive collaboration between OSF HealthCare, Pointcore (and its predecessor, St. Francis, Inc.) and GE HealthCare across many initiatives such as improving the delivery of healthcare technology management and advancements in diagnostic imaging technology. Collaboration activities will begin in the Spring of 2024 with the launch of the OSF HealthCare Cancer Institute in Peoria, Illinois.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with 51,000 colleagues working to create a world where healthcare has no limits.
Follow us on LinkedIn, Twitter, and Insights for the latest news, or visit our website https://www.gehealthcare.com/ for more information.
About OSF HealthCare
OSF HealthCare is an integrated health system founded by The Sisters of the Third Order of St. Francis. Headquartered in Peoria, Illinois, OSF HealthCare has 16 hospitals – 10 acute care, five critical access, 1 transitional care - with 2,131 licensed beds throughout Illinois and Michigan. OSF employs nearly 24,000 Mission Partners across 150+ locations; has two colleges of nursing; operates OSF Home Care Services, an extensive network of home health and hospice services; owns Pointcore, Inc., comprised of health care-related businesses; OSF HealthCare Foundation, the philanthropic arm for the organization; and OSF Ventures, which provides investment capital for promising health care innovation startups. In 2020, OSF OnCall was established, a digital health operating unit, including a hospital-at-home. OSF OnCall delivers care and services when, where and how patients prefer to receive them. OSF HealthCare has been recognized by Fortune as one of the most innovative companies in the country. More at osfhealthcare.org.
About Pointcore , Inc.
Pointcore serves the healthcare industry through proven excellence in key services that enable patient care including technology services (application, IT, network and cybersecurity), healthcare technology management (HTM or biomedical equipment services), supply chain, business and construction. As an extension of OSF HealthCare, one of the nation’s leading healthcare organizations, Pointcore leverages decades of experience serving hospitals and clinics of all sizes to extend resources, share cost and utilize common infrastructure with external clients, all to the benefit of patients. Learn more about Pointcore innovation by following us on LinkedIn and at Pointcore.com.
Last Trade: | US$77.09 |
Daily Change: | -2.16 -2.73 |
Daily Volume: | 3,055,620 |
Market Cap: | US$35.220B |
December 05, 2024 December 03, 2024 December 01, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB